Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELD

Liver Transplantation

Volumn 11, Issue 11, 2005, Pages 1315-1317

  Stock, Peter G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIRETROVIRUS AGENT; LAMIVUDINE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; CONSULTATION; DETERIORATION; DISEASE EXACERBATION; DRUG TOLERABILITY; EDITORIAL; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; SAFETY; SCORING SYSTEM; SOCIAL SUPPORT; SUPERINFECTION; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CAUSE OF DEATH; COMORBIDITY; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; WAITING LISTS;

EID: 30444447087     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20539     Document Type: Editorial

References (12)

1. Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005;34:121-130.
2. Teicher E VD, Duclos-Valles J, Azulay D, Castaing D, Bismuth H, Roque-Afonso A, et al. Liver transplantation in HIV-HCV co-infected patients. Presented at 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2004.
3. Rufi G BR, Vargas V, Valdivieso A, Miro JM, Salcedo M, Rafecas A, et al. and the Spanish OLT-HIV Working Group. Orthotopic liver transplantation in 15 HIV-1-infected recipients: evaluation of Spanish experience in the HAART era (2002-2003). Presented at 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2004.
4. Vogel M BH, Effenberger W, Wolff M, Rockstroh JK, Hirner A, Sauerbruch T, et al. Clinical outcome of orthotopic liver transplantation in HIV-infected patients: a report of 4 cases from the Bonn cohort. Eur J Med Res 2003;8:71.
5. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003;76:370-375.
6. Samuel D, Duclos Vallee JC, Teicher E, Vittecoq D. Liver transplantation in patients with HIV infection. J Hepatol 2003;39: 3-6.
7. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003;75:425-429.
8. Ragni MV, Belle SH, Im K, Neff G, Roland M, Stock P, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003;188:1412-1420
9. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003;9:239-247.
10. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004;15:1633-1639.
11. Ragni M, Eghtesad B, Schlesinger K, et al. Pre-transplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 2005;xxx:xx-xx.
12. Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E. Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant 2005;5:1319-1325.